# Pharmacologically Actionable Explainability

**Knowledge set ID:** `dd-025-explainability-actionability`  
**Theme:** `drug-discovery`  
**Source:** Explainability considerations for AI-driven drug discovery  

## Curated Content

Explainability in AI-driven drug discovery should be pharmacologically actionable. A model may
provide feature importance, attention weights, embeddings, or graph paths, but these outputs are not
always meaningful to a pharmacologist or clinician. Useful explanations connect the drug to a
target, the target to disease biology, and the expected direction of pathway modulation.  A
pharmacologically useful explanation should also discuss whether the mechanism creates safety
concerns. For example, if a disease pathway is overactive, the proposed drug should plausibly reduce
that pathway rather than further stimulate it. If the same mechanism is needed in healthy tissue,
the safety risk should be considered.  The agent should therefore avoid saying that a model
explanation proves causality. An interpretable path or high prediction score is a hypothesis.
Clinical and pharmacological actionability requires mechanism, dose feasibility, exposure, safety,
and validation evidence.

## Key Concepts

- `explainability`
- `mechanism-of-action`
- `pharmacology`
- `safety`

## Retrieval Note

This self-contained knowledge set is used by the agent for grounded drug-discovery Q&A, benchmark citation, memory distillation, and dynamic orchestration evidence.
